|
ClinorilDrug - Clinoril The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Sulindac
Strength -
200MG
Applicant -
MERCK
New Drug Application (NDA) Number -
017911
Product Number -
002
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Merck Research Laboratories Div Merck Co Inc
Clinoril
Gantrisin Eq 4% Base Solution/drops; Ophthalmic
Sulfisoxazole Diolamine Eq 4% Base Solution/drops; Ophthalmic Diasone Sodium 165mg Tablet, Delayed Release; Oral Bensulfoid 33.32% Powder; Topical Clinoril 150mg Tablet; Oral Clinoril 200mg Tablet; Oral Gantrisin Pediatric Eq 500mg Base/5ml Suspension; Oral Gantrisin Eq 500mg Base/5ml Syrup; Oral Gantrisin Eq 400mg Base/ml Injectable; Injection Gantrisin Eq 4% Base Ointment; Ophthalmic NewDrugInformation |